NAS10031,337+0.84%S&P7,841+0.86%GOLD$4,194+0.90%BTC$86,011+0.26%VIX15.30−1.42%live tape · as of 15:50 UTC
The Screen · Financials · Banks - Regional
Lloyds Banking Group plc ADR
LYG · the NYSE · USD · Market cap $83.2B · 60,061 employees
Lloyds Banking Group plc, together with its subsidiaries, provides a range of banking and financial products and services for retail and commercial customers in the United Kingdom.
FAIL · Does not pass the screen
5.77 USD
Screen close, 2026-09-25 · not a live quote Last reviewed 11 days ago
Screened 2026-09-25 · the tape above runs as of 15:50 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
PRICE · FAIR-VALUE RANGE1M3M6MYTD1Y3Y5Y
What this means: price 5.77 against the desk's fair-value range, base estimate 7.56, over the last year.
Positioning no disclosures inside 60 days, left as found
Options no verdict drawn today, left as found
Ethical does not pass the values gate
Price5.77 USD
Fair value7.56
Ethical score30.0/100
Our investment reviews on this name
2026-08-30Read Markdown5.90-2.2% to today ✓
2026-07-18Read Markup5.50+4.9% to today ✓
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Lloyds Banking Group plc ADR holds its Markdown at $5.77. Consolidating, no directional conviction, held for 10 days.
As held on the ledger · 2026-09-25
Phase
Markdown · caution
Quantitative state
Consolidating, no directional conviction, held for 10 days
Price at the screen
$5.77
Valuation
13.42 trailing · 8.98 forward price to earnings
Values screen
FAIL· score 30.0
Beta
0.91
The Workings
Five Screens, Shown in Full
Does not pass. Excluded industry: Banks - Regional
Test
Figure
Limit
What it means
Status
Business activity
Excluded
Core business clean
Excluded industry: Banks - Regional
Fail
Debt load
Excluded
Below 33%
Interest-bearing debt is of its assets, above the one-third ceiling the screen allows.
Fail
Interest-bearing cash
Excluded
Below 33%
Interest-bearing cash and securities are of assets, above the one-third limit.
Fail
Receivables
Excluded
Below 49%
Money owed to the company is of assets, above the 49% limit.
Fail
Revenue purity
Excluded
Below 5%
of revenue comes from non-compliant sources, over the 5% line.
Fail
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Falls Short, in Plain English
Lloyds Banking does not clear the screen at the business-activity stage. It operates in conventional financial services, which the screen treats as interest-based, so the financial ratios are not the deciding factor here.
Read as at 2026-10-04. It updates when the underlying figures move, and past reads are kept below.
Fair value range in USD, drawn from the 2026-09-25 screen. The gold marker is the market price at the same screen. A 31.0% margin of safety to the base estimate.
Third-party analyst targets: 4 covering, consensus Buy. The average target sits +11% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-25 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
High street banks hit ethical walls first
Step into any branch on a British high street and the daily flow of wages, mortgages and small business loans looks ordinary enough. Lloyds handles that work through its retail, commercial and insurance arms, showing 12 percent revenue growth and a 26 percent profit margin at a 9.4 times forward multiple.
We pass regardless. The group fails our ethical screen on the excluded industry of regional banks, so narrow moats, 11 percent returns on equity and an 18 percent margin of safety never enter the conversation. Opportunity rating stays at none.
The screen keeps whole sectors out because their social footprint sits too large, no matter what analysts call a hold or where the price sits versus our fair value. Analysis, not advice.
The risks · The things to watch: its business and earnings are exposed to United Kingdom and to currency swings.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
LYG trades on the NYSE (the company is based in United Kingdom). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-10-02Markdown$5.77-2.2%Entry 12
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 2.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 9% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 30%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (3 analysts) rates it none, with a mean price target of $6.
2026-08-30Markdown · changed$5.90-2.0%Entry 11
The framework has shifted from markup to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 2.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 9% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 30%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (3 analysts) rates it none, with a mean price target of $6.
2026-07-30Markup$6.02+0.0%Entry 10
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 9% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 30%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (3 analysts) rates it none, with a mean price target of $6. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-28Markup$6.02+0.0%Entry 9
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 9% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 30%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (3 analysts) rates it none, with a mean price target of $6. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-27Markup$6.02+0.0%Entry 8
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 9% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 30%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (3 analysts) rates it none, with a mean price target of $6. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-26Markup$6.02+0.0%Entry 7
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 9% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 30%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (3 analysts) rates it none, with a mean price target of $6. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-25Markup$6.02+1.0%Entry 6
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 1.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 9% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 30%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (3 analysts) rates it none, with a mean price target of $6. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-24Markup$5.96+0.0%Entry 5
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 9% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 30%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (3 analysts) rates it none, with a mean price target of $6. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-23Markup$5.96+8.4%Entry 4
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 8.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 9% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 30%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (3 analysts) rates it none, with a mean price target of $6. It reported earnings in this window, a natural checkpoint for the thesis.
2026-07-18Markup$5.50+0.0%Entry 3
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 9% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 30%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (3 analysts) rates it none, with a mean price target of $6.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
